Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients

Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients ID - 454852 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454852/all/Thienopyridine_derivatives__ticlopidine__clopidogrel__versus_aspirin_or_aspirin_dipyridamole_for_preventing_serious_vascular_events_in_high_risk_patients PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -